Although the focus of our studies was the β-catenin-CEGRs/ALCDs pathway, it is likely that the promoters of cancer-associated genes, such as the AFP gene, have TCF4 binding sites and may be activated by β-catenin without the assistance of CEGRs/ALCDs. This evidence concerns the gene TCF4 and cancer.